At any sign of further weakness, AAPL is still looking like a buy.
Ron Cohen, CEO of Acorda Therapeutics, says his company's pipeline is full and he is less worried about Obamacare than the FDA.
It's a banner day for the blue chips as Wall Street puts worries about Europe aside after a round of solid earnings reports.
Without Apple's leadership, it will be tough for the market to escape its recent funk.
The situation for NOK is bad and getting worse. Still, the company is a survivor.
Apple reports second-quarter earnings Tuesday after the bell. As a new iPhone gets set to launch, will iPhone sales stall or will they continue to soar?
These stocks, which go ex-dividend Wednesday, are rated buy at TheStreet Ratings.
Apple reports second-quarter earnings after the close of trading. TheStreet wants to know how you think the stock will perform.
AT&T beat analysts' earnings estimates Tuesday, boosted by strong wireless sales and its smartphone business.
Apple, AT&T and 3M report earnings on Tuesday.